FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

890531000168106: Candesartan HCTZ 32/12.5 (DRLA) (candesartan cilexetil 32 mg + hydrochlorothiazide 12.5 mg) tablet (trade product unit of use)

Status: current, Defined. Date: 31-Mar 2017. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
1816391000168119 Candesartan HCTZ 32/12.5 (DRLA) (candesartan cilexetil 32 mg + hydrochlorothiazide 12.5 mg) uncoated tablet (trade product unit of use) en Fully specified name Inactive Case sensitive Australian Medicines Terminology module
1816401000168117 Candesartan HCTZ 32/12.5 (DRLA) uncoated tablet en Synonym Inactive Case sensitive Australian Medicines Terminology module
3902681000168110 Candesartan HCTZ 32/12.5 (DRLA) (candesartan cilexetil 32 mg + hydrochlorothiazide 12.5 mg) tablet (trade product unit of use) en Fully specified name Active Case sensitive Australian Medicines Terminology module
3902691000168113 Candesartan HCTZ 32/12.5 (DRLA) tablet en Synonym Active Case sensitive Australian Medicines Terminology module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Candesartan HCTZ 32/12.5 (DRLA) tablet has manufactured dose form tablet true Inferred relationship Some
Candesartan HCTZ 32/12.5 (DRLA) tablet Is a trade product unit of use true Inferred relationship Some
Candesartan HCTZ 32/12.5 (DRLA) tablet Is a candesartan cilexetil 32 mg + hydrochlorothiazide 12.5 mg tablet true Inferred relationship Some
Candesartan HCTZ 32/12.5 (DRLA) tablet Is a Candesartan HCTZ 32/12.5 (DRLA) true Inferred relationship Some
Candesartan HCTZ 32/12.5 (DRLA) tablet has manufactured dose form uncoated tablet false Inferred relationship Some
Candesartan HCTZ 32/12.5 (DRLA) tablet has unit of use tablet true Inferred relationship Some 2040544318
Candesartan HCTZ 32/12.5 (DRLA) tablet has Australian BoSS candesartan cilexetil true Inferred relationship Some 2040544317
Candesartan HCTZ 32/12.5 (DRLA) tablet has intended active ingredient candesartan true Inferred relationship Some 2040544317
Candesartan HCTZ 32/12.5 (DRLA) tablet has Australian BoSS hydrochlorothiazide true Inferred relationship Some 1619485268
Candesartan HCTZ 32/12.5 (DRLA) tablet has intended active ingredient hydrochlorothiazide true Inferred relationship Some 1619485268
Inbound Relationships Type Active Source Characteristic Refinability Group
Candesartan HCTZ 32/12.5 (DRLA) tablet, 7 has TPUU True Candesartan HCTZ 32/12.5 (DRLA) tablet Inferred relationship Some 1
Candesartan HCTZ 32/12.5 (DRLA) tablet, 30 has TPUU True Candesartan HCTZ 32/12.5 (DRLA) tablet Inferred relationship Some 1
Candesartan HCTZ 32/12.5 (DRLA) tablet, 10, blister pack has TPUU True Candesartan HCTZ 32/12.5 (DRLA) tablet Inferred relationship Some 1
Candesartan HCTZ 32/12.5 (DRLA) tablet, 10 has TPUU True Candesartan HCTZ 32/12.5 (DRLA) tablet Inferred relationship Some 1
Candesartan HCTZ 32/12.5 (DRLA) tablet, 30, blister pack has TPUU True Candesartan HCTZ 32/12.5 (DRLA) tablet Inferred relationship Some 1
Candesartan HCTZ 32/12.5 (DRLA) tablet, 7, blister pack has TPUU True Candesartan HCTZ 32/12.5 (DRLA) tablet Inferred relationship Some 1

Reference Sets

Trade product unit of use reference set

Back to Start